Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.66 USD | +1.47% | +18.65% | +4.08% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 642M |
---|---|---|---|---|---|
Net income 2024 * | -123M | Net income 2025 * | -148M | EV / Sales 2024 * | - |
Net cash position 2024 * | 267M | Net cash position 2025 * | 153M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.21
x | P/E ratio 2025 * |
-4.81
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.48% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 day | +2.04% | ||
1 week | +24.12% | ||
Current month | +7.81% | ||
1 month | -21.77% | ||
3 months | -15.23% | ||
6 months | +41.04% | ||
Current year | +3.48% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.48% | 4 M€ | -5.15% | - | |
0.03% | 2 M€ | -.--% | ||
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 9.575 | +0.58% | 162 971 |
24-05-02 | 9.52 | +2.04% | 555,938 |
24-05-01 | 9.33 | +5.66% | 762,455 |
24-04-30 | 8.83 | +7.29% | 761,332 |
24-04-29 | 8.23 | +1.98% | 425,342 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.48% | 642M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.58% | 23.07B | |
-12.60% | 22.23B | |
-4.92% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- ORIC Stock